Bevacizumab and disease progression 
Bevacizumab and disease progression Patient Reports February 10, 2012
Bevacizumab Side Effects Report #4872530-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 30, 2005. Male patient, weighting 182.0 lb, was diagnosed with transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, disease progression, intestinal perforation. Bevacizumab dosage: 15 MG PER KG Q 3 WKS IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6014991-9
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on May 22, 2006. Female patient, 75 years of age, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, disease progression, dyspepsia, haemoglobin decreased, peritoneal haemorrhage. Bevacizumab dosage: 5 MG/M2, UNK. Patient died on 12/28/2005.
Bevacizumab Side Effects Report #5550823-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 28, 2007. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, gastric ulcer. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, POLYCARBOPHIL, LACTOBACILLUS BIFIDUS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5575301-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 14, 2007. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, gastric ulcer, hepatic failure, tooth extraction. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, POLYCARBOPHIL, LACTOBACILLUS BIFIDUS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5571926-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 10, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, sepsis
. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with FLUOROURACIL, ISOVORIN, OXALIPLATIN, CYTOTEC, DICLOFENAC, LOXONIN, MORPHINE ELIXIR, NORVASC. Patient died on 11/10/2007.Bevacizumab Side Effects Report #5685070-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 13, 2008. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase abnormal, anorexia, aspartate aminotransferase abnormal, blood bilirubin abnormal, blood potassium increased, condition aggravated, disease progression. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with FLUOROURACIL, ISOVORIN, OXALIPLATIN, CYTOTEC, DICLOFENAC, LOXONIN, MORPHINE ELIXIR, NORVASC. Patient died on 11/10/2007.
Bevacizumab Side Effects Report #4647220-9
Bevacizumab side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 68 years of age, weighting 205.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: balance disorder, disease progression, optic ischaemic neuropathy, optic neuritis, papilloedema, visual acuity reduced. Bevacizumab dosage: 10 MG/KB IV Q 2 WEEKS. During the same period patient was treated with LUPRON, CASODEX. Patient recovered.Bevacizumab Side Effects Report #5331087-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 18, 2007. Female patient, 67 years of age, weighting 97.00 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, faeces discoloured, haematocrit decreased, upper gastrointestinal haemorrhage. Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, AMBIEN, ACETYLSALICYLIC ACID SRT, COMPAZINE, CREON, LIPITOR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5622855-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2008. Female patient, 55 years of age, weighting 132.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pulmonary embolism
, thrombocytopenia. Bevacizumab dosage: 10MG/KG DAYS 1 AND 15 IV, OVER 30 MIN.. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5409520-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Male patient, 52 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 10 MG/MG2 IV BOLUS. During the same period patient was treated with GEMCITABINE, ERLOTINIB D, ATIVAN, CELEXA, COLACE, LIDOCAINE, MIRALAX, OXYCODONE. Patient died on 08/06/2007.
Bevacizumab Side Effects Report #5440538-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 27, 2007. Male patient, 52 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, pancreatic carcinoma metastatic. Bevacizumab dosage: 10 MG/M2, DAYS 1+15/28DC. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATIVAN, CELEXA, LIDOCAINE MAALOX, DIPHENHYDRAMINE, REGLAN, SENNA. Patient died on 08/06/2007.
Bevacizumab Side Effects Report #5562787-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient, weighting 94.80 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bile duct obstruction, disease progression, gastrointestinal haemorrhage, neutropenia, white blood cell count increased. Bevacizumab dosage: 450MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.
Bevacizumab Side Effects Report #6092356-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2009. Male patient, weighting 201.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, disease progression, nausea . Bevacizumab dosage: 15MG/KG, 1370 MG EVERY 3 WEEKS IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5208959-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2007. Female patient, 62 years of age, weighting 94.00 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, infection
, lung neoplasm, metastases to lung, pain , pulmonary embolism . Bevacizumab dosage: 446.00 MG Q 2 WEEKS IV. Patient was hospitalized. Patient died on 08/28/2006.Bevacizumab Side Effects Report #4840165-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 11, 2005. Female patient, 71 years of age, weighting 123.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal abscess, blood sodium decreased, catheter related complication, colonic fistula, culture positive, disease progression, enteritis, enterococcal infection. Bevacizumab dosage: 840 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ATIVAN, VICODIN, VITAMIN C, CALCIUM. Patient was hospitalized. Patient died on 11/04/2005.
Bevacizumab Side Effects Report #4780314-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 09, 2005. Female patient, 59 years of age, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium increased, blood phosphorus decreased, contrast media reaction, convulsion, disease progression, haematocrit decreased, haemoglobin decreased, heart rate increased. Bevacizumab dosage: 825 MG, Q3W, INTRAVENOUS. During the same period patient was treated with NIFEDIPINE, PAXIL, NEUTRA, MAGNESIUM SULPHATE, LACTULOSE, MEGACE, PRILOSEC, CIPROFLOXACIN. Patient was hospitalized. Patient died on 08/02/2005.
Bevacizumab Side Effects Report #5483688-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea haemorrhagic, disease progression, dyspnoea, hypotension, small intestinal obstruction, west nile viral infection. Bevacizumab dosage: 10 MG QCD1 IV. During the same period patient was treated with CISPLATIN, DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5608791-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depressed level of consciousness, disease progression, dyspnoea, encephalopathy, hypotension, small intestinal obstruction, virus serology test positive. Bevacizumab dosage: 10 MG QCD1 AND8 IV. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5804416-8
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on July 07, 2008. Male patient, 59 years of age, weighting 125.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, lung disorder, pneumothorax. Bevacizumab dosage: 900MG EVERY 3 WEEKS IV. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5223436-8
Bevacizumab side effect was reported by a Physician from POLAND on Jan 12, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cold agglutinins positive, disease progression, epistaxis. Bevacizumab dosage: 7.5 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5232395-3
Bevacizumab side effect was reported by a Physician from POLAND on Jan 19, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cold agglutinins positive, disease progression, epistaxis. Bevacizumab dosage: 7.5 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4939196-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2006. Male patient, 66 years of age, weighting 172.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decreased appetite, disease progression, dry mouth, malignant neoplasm progression, multi-organ failure, non-small cell lung cancer metastatic, pneumonia
, pneumonia viral, pneumonitis. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with PEMETREXED ELI LILY, FOLATE, ATIVAN, ZOLOFT, DIGOXIN, COMPAZINE, ATENOLOL, ALLEGRA. Patient was hospitalized. Patient died on 03/03/2006.Bevacizumab Side Effects Report #5252909-7
Bevacizumab side effect was reported by a Physician from FRANCE on Feb 07, 2007. Female patient, 58 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, disease progression, hypertension, international normalised ratio increased, thrombosis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, LOVENOX, RABEPRAZOLE, ATACAND, ATENOLOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5392589-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 11, 2007. Male patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, radiation pneumonitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with RADIATION, PACLITAXEL, CARBOPLATIN. Patient recovered.
Bevacizumab Side Effects Report #4964273-9
Bevacizumab side effect was reported by a Health Professional from FRANCE on Mar 16, 2006. Male patient, 53 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, leriche syndrome. Bevacizumab dosage: 15 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, DIPOTASSIUM CLORAZEPATE, SOLUPRED, RABEPRAZOLE, POLYSILANE, LEVOMEPROMAZINE, INNOHEP. Patient recovered.
Bevacizumab Side Effects Report #4981262-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 12, 2005. Female patient, 46 years of age, weighting 209.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, duodenal perforation, escherichia urinary tract infection, haemoglobin decreased, ileus, lung neoplasm, pancreatic cyst. Bevacizumab dosage: 1418 MG, Q3W, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, LIPITOR, LASIX, COREG, PRINIVIL, POTASSIUM CHLORIDE, AMPICILLIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5376201-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 22, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pulmonary hypertension
. Bevacizumab dosage: 10 MG/KG, QOW. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient recovered.Bevacizumab Side Effects Report #5295197-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 28, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, agitation, bowel sounds abnormal, constipation
, cyanosis, disease progression, dyspepsia, fall , left ventricular failure. Bevacizumab dosage: 1380 MG, QD. During the same period patient was treated with ERLOTINIB, IPRATROPIUM BROMIDE, ASPIRIN, TRIATEC, ADALAT, DAFALGAN, PANTOZOL, HEPARIN. Patient was hospitalized. Patient died on 12/11/2006.Bevacizumab Side Effects Report #5326312-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, disease progression, epistaxis, haemorrhage, mouth haemorrhage, unevaluable event, vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, CETUXIMAB, COUMADIN. Patient died.Bevacizumab Side Effects Report #5487181-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, disease progression, muscular weakness, neutropenic infection, neutrophil count decreased, pneumonia
. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ERBITUX, TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5701286-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, SEVREDOL. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #5703474-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2008. Male patient, weighting 325.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 1005 MG, Q3W. Patient died on 03/01/2008.
Bevacizumab Side Effects Report #5962384-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2008. Male patient, weighting 142.0 lb, was diagnosed with non-small cell lung cancer, metastases to bone, hypomagnesaemia, anaemia, white blood cell count decreased and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN, ZOMETA, MAGNESIUM SULPHATE, PROCRIT, NEULASTA. Patient died on 10/24/2007.
Bevacizumab Side Effects Report #5965107-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 11, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: catheter sepsis, cholelithiasis, disease progression, enterococcal sepsis, gastric neoplasm, pancreatitis acute, pneumonia
. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMZAR, CARBOPLATIN, AUGMENTIN, KLACID, CEFEPIME, VANCOMYCIN, AMOXICILLIN. Patient recovered.Bevacizumab Side Effects Report #6009214-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 28, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pericardial effusion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient died on 08/24/2006.
Bevacizumab Side Effects Report #6055821-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 16, 2009. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, MORPHINE, ONDANSETRON. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #5849652-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2008. Male patient, weighting 165.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, tachycardia. Bevacizumab dosage: 15 MG/KG, Q21D. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5886888-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 02, 2008. Male patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ataxia
, confusional state, disease progression, muscular weakness, nuclear magnetic resonance imaging brain abnormal. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTRON A, INTRON A. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5728615-9
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 02, 2008. Female patient, 30 years of age, weighting 94.80 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 345MG (7.5MG/KG) EVERY 21 DAYS IV. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6106448-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2009. Male patient, weighting 117.1 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, disease progression, loss of consciousness, nausea , weight decreased. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, MS CONTIN, OXALIPLATIN, TYLENOL W. Patient was hospitalized. Patient died on 02/21/2009.Bevacizumab Side Effects Report #4911878-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 13, 2006. Male patient, 71 years of age, weighting 124.6 lb, was diagnosed with mesothelioma
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 15MG/KG = 850MG Q21DAYS IV. During the same period patient was treated with TARCEVA. Patient died on 02/08/2005.Bevacizumab Side Effects Report #4744411-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2005. Female patient, 65 years of age, was diagnosed with mesothelioma
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, mesothelioma malignant. Bevacizumab dosage: 15 MG/KG IV Q 21 DAYS. During the same period patient was treated with ERLOTINIB, ZANTAC, LIPITOR, FOSAMAX, LORAZEPAM, AMBIEN, FOLIC ACID, ARANESP. Patient died on 07/26/2005.Bevacizumab Side Effects Report #5921260-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2008. Female patient was diagnosed with malignant melanoma, metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, disease progression, muscular weakness. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTERFERON ALFA, INTERFERON ALFA. Patient recovered.
Bevacizumab Side Effects Report #4556586-X
Bevacizumab side effect was reported by a Consumer or non-health professional from on Dec 22, 2004. Male patient, 52 years of age, weighting 123.5 lb, was diagnosed with lip and/or oral cavity cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, mucosal inflammation, oesophagitis. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, METHOTREXATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5887070-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2008. Female patient was diagnosed with head and neck cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, respiratory failure. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ERBITUX. Patient died on 06/27/2008.Bevacizumab Side Effects Report #5173443-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2006. Female patient, weighting 119.3 lb, was diagnosed with glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, convulsion, disease progression, hemiparesis, mental status changes, pyrexia, refusal of treatment by patient, refusal of treatment by relative, urinary incontinence . Bevacizumab dosage: 566MG QOW IV. During the same period patient was treated with IRINOTECAN, HYDROCHLOROTHIAZIDE, DEXAMETHASONE, ACIPHEX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5903619-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 15, 2008. Male patient, 66 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, encephalopathy, lethargy. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient recovered.
Bevacizumab Side Effects Report #5133976-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 02, 2006. Male patient, 59 years of age, weighting 222.0 lb, was diagnosed with glioblastoma multiforme, oedema and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, blood glucose increased, blood sodium decreased, disease progression, electromechanical dissociation, haematocrit decreased, haemoglobin decreased, hypoxia, lobar pneumonia. Bevacizumab dosage: 977 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DECADRON, KEPPRA, PRAVASTATIN, PEPCID, EFFEXOR. Patient was hospitalized. Patient died on 10/04/2006.
Bevacizumab Side Effects Report #5466830-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 17, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, abscess
, asthenia, convulsion, disease progression, fall , pulmonary mass. Bevacizumab dosage: 805MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, SYNTHROID, ASPIRIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5477706-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disease progression, fall
, hemiparesis, hypotension, lung neoplasm, pneumonia , tachycardia. Bevacizumab dosage: 805MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, SYNTHROID, ASPIRIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5470252-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2007. Male patient, 49 years of age, weighting 230.6 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 2018 MG, DAYS 1+15. During the same period patient was treated with IRINOTECAN, BACTRIM, DECADRON, KEPPRA, PEPCID. Patient died on 08/23/2007.
Bevacizumab Side Effects Report #5492634-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 2007. Male patient, 49 years of age, weighting 230.6 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 2018 MG, DAYS 1+15. During the same period patient was treated with IRINOTECAN, BACTRIM, DECADRON, KEPPRA, PEPCID. Patient died on 08/23/2007.
Bevacizumab Side Effects Report #5527036-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2007. Male patient, 49 years of age, weighting 230.6 lb, was diagnosed with glioblastoma multiforme, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, glioblastoma. Bevacizumab dosage: 2018 MG, DAYS 1+15. During the same period patient was treated with IRINOTECAN, BACTRIM, DECADRON, KEPPRA, PEPCID, ALOXI, BENADRYL. Patient died on 08/23/2007.
Bevacizumab Side Effects Report #5935684-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2008. Male patient, 45 years of age, weighting 175.3 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disease progression, pain
. Bevacizumab dosage: 810MG Q2WKS IV. During the same period patient was treated with TEMOZOLOMIDE, PRINIVIL, FIORICET, DARVON, FLEXERIL. Patient died on 05/09/2008.Bevacizumab Side Effects Report #5512611-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 08, 2007. Male patient, 44 years of age, weighting 242.5 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholelithiasis, disease progression, hyperglycaemia, hypertension, pancreatitis acute. Bevacizumab dosage: 1230MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, HYDROCHLOROTHIAZIDE, NEXIUM, XANAX, FLEXERIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5297826-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, disease progression, fall
, hyponatraemia, nausea , pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5329901-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, disease progression, haemorrhage, headache
, hypoaesthesia, no therapeutic response. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, NORVASC, DEXAMETHASONE, PEPCID, DILANTIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5332315-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, disease progression, haemorrhage, headache
, hypoaesthesia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, NORVASC, DEXAMETHASONE, PEPCID, DILANTIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5505219-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 22, 2007. Female patient was diagnosed with glioblastoma multiforme, hypertension, fatigue, oedema, infection
, gastrooesophageal reflux disease and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with VASOTEC, RITALIN, DECADRON, BACTRIM, FLUCONAZOLE, ZANTAC. Patient died on 09/24/2007.Bevacizumab Side Effects Report #5571964-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 17, 2007. Female patient, weighting 186.3 lb, was diagnosed with glioblastoma multiforme, fatigue, headache
, insomnia, dyspepsia, hypothyroidism, depression , deep vein thrombosis , convulsion and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, hypernatraemia. Bevacizumab dosage: 745 MG, Q2W. During the same period patient was treated with PROVIGIL, CODEINE, AMBIEN, PROTONIX, LEVOTHYROXINE, NORTRIPTYLINE, LOVENOX, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5592311-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Female patient, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 536 MG, Q2W. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 10/21/2007.
Bevacizumab Side Effects Report #6081133-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 09, 2009. Male patient, weighting 256.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, fatigue, muscular weakness. Bevacizumab dosage: 5 MG/KG, D1. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5232175-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2007. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, disease progression, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.Bevacizumab Side Effects Report #5221067-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 08, 2007. Female patient, 45 years of age, weighting 222.7 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. Patient died.
Bevacizumab Side Effects Report #5610954-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 30, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, c-reactive protein increased, deep vein thrombosis , depression , disease progression, ileus, infection , pyrexia, small intestinal obstruction. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4997117-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Male patient, 69 years of age, weighting 201.0 lb, was diagnosed with gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia. Bevacizumab dosage: 15 MG/KG D1 EACH 21D IV DRIP. During the same period patient was treated with OXALIPLATIN SANOFI, DOCETAXEL AVENTIS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5596039-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 08, 2008. Male patient, weighting 112.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 390 MG, Q3W. During the same period patient was treated with CAPECITABINE, LOPERAMIDE, GLUTAMINE, METOCLOPRAMIDA, PANTOPRAZOLE, RANIDINE, METAMIZOL. Patient died on 12/23/2007.
Bevacizumab Side Effects Report #5950883-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Female patient, weighting 119.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pulmonary fibrosis
. Bevacizumab dosage: 278 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ACTONEL, ATIVAN, CLARITIN. Patient recovered.Bevacizumab Side Effects Report #6019611-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 16, 2008. Female patient, weighting 119.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pulmonary fibrosis
. Bevacizumab dosage: 278 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ACTONEL, ATIVAN, CLARITIN. Patient recovered.Bevacizumab Side Effects Report #4670232-6
Bevacizumab side effect was reported by a Physician from on May 02, 2005. Male patient, 81 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, aspiration, atrial fibrillation , disease progression, hypotension, loss of consciousness, myocardial ischaemia, nausea , neutropenia. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, CALCIUM LEUCOVORIN, FLUOROURACIL. Patient was hospitalized. Patient died on 02/06/2003.Bevacizumab Side Effects Report #5635494-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 07, 2008. Female patient, weighting 193.0 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, OXALIPLATIN, MORPHINE, ANTI NAUSEA MEDICINE UNKOWN NAME, CLONIDINE. Patient died on 01/13/2008.Bevacizumab Side Effects Report #5714966-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 13, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, TOLTERODINE TARTRATE. Patient died on 09/11/2006.Bevacizumab Side Effects Report #5721937-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea , renal failure. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5731118-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 23, 2008. Male patient, weighting 176.4 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, disease progression. Bevacizumab dosage: 400 MG, 1/WEEK. During the same period patient was treated with XELODA, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6028916-3
Bevacizumab side effect was reported by a Physician from GREECE on Dec 23, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: biliary cirrhosis primary, cardiac failure, cardiotoxicity, diarrhoea, disease progression, hepatic failure, mucosal inflammation, nausea , pancytopenia. Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with CAPECITABINE, IRINOTECAN, DEXAMETHASONE, ATROPINE, TACROLIMUS. Patient died.Bevacizumab Side Effects Report #5876927-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 28, 2008. Male patient, weighting 113.8 lb, was diagnosed with colon cancer recurrent, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, duodenal ulcer. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with DECADRON SRC, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZANTAC, SEROTONE, DECADRON SRC, MAGMITT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5933993-1
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2008. Male patient, weighting 113.8 lb, was diagnosed with colon cancer recurrent, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, duodenal ulcer. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with DECADRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZANTAC, SEROTONE, MAGMITT. Patient was hospitalized. Patient died on 04/21/2008.
Bevacizumab Side Effects Report #5938698-9
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2008. Male patient, weighting 113.8 lb, was diagnosed with colon cancer recurrent, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cachexia, disease progression, duodenal ulcer. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with DECADRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZANTAC, SEROTONE, MAGMITT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5246603-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2007. Female patient, weighting 141.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, jaundice
, metastases to liver, pain , peritoneal carcinoma. Bevacizumab dosage: 5MG/KG Q 2 WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5640855-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 12, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: candida pneumonia, disease progression. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5655660-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 22, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, disease progression, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, AMLODIPINE, DECADRON, FAMOTIDINE, GASTROM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5695897-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: candida pneumonia, disease progression. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5789342-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 11, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, disease progression. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, LOXONIN. Patient recovered.
Bevacizumab Side Effects Report #5792244-1
Bevacizumab side effect was reported by a Physician from JAPAN on June 13, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, disease progression, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, AMLODIPINE, DECADRON, FAMOTIDINE, GASTROM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5814027-6
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on June 19, 2008. Female patient, weighting 88.18 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea
, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, CALCIUM LEVOFOLINATE, DECADRON, NOVAMIN, DOMPERIDON, ACARBOSE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5922238-4
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 02, 2008. Female patient, weighting 88.18 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea
, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, DECADRON, NOVAMIN, DOMPERIDON, ACARBOSE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5483055-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 26, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alveolitis allergic, arterial spasm, cardiac failure, cardio-respiratory arrest, disease progression, pulmonary embolism
, pulmonary hypertension , shock, tumour embolism. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL. Patient recovered.Bevacizumab Side Effects Report #5514761-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 29, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal perforation, intestinal obstruction, wound dehiscence. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, KYTRIL, DECADRON, AMOBAN. Patient died on 10/03/2007.
Bevacizumab Side Effects Report #5719040-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adhesion
, ascites, disease progression. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5751096-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 13, 2008. Female patient was diagnosed with colon cancer, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, epistaxis, hypertension, proteinuria, renal failure acute. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, CALCIUM GLUCONATE, MAGNESOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5754788-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal adhesions, ascites, disease progression. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5773109-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 29, 2008. Female patient was diagnosed with colon cancer, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, epistaxis, hypertension, proteinuria, renal failure acute. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, CALCIUM LEVOFOLINATE, FLUOROURACIL, CALCIUM GLUCONATE, MAGNESOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5706288-9
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Mar 31, 2008. Female patient, weighting 171.7 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, delirium, disease progression. Bevacizumab dosage: 779 MG, Q2W. During the same period patient was treated with PACLITAXEL, OXYCODONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5726573-4
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2008. Female patient, weighting 171.7 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, delirium, disease progression. Bevacizumab dosage: 779 MG, Q2W. During the same period patient was treated with PACLITAXEL, OXYCODONE, LOXOPROFEN, ACETAMINOPHEN, ALPRAZOLAM, GUALENATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5741093-9
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2008. Female patient, weighting 171.7 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: delirium, disease progression. Bevacizumab dosage: 779 MG, Q2W. During the same period patient was treated with PACLITAXEL, OXYCODONE, MORPHINE ELIXIR, LOXOPROFEN, ACETAMINOPHEN, ALPRAZOLAM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5874199-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 24, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 480 MG, Q2W. During the same period patient was treated with PACLITAXEL, ZOMETA. Patient died on 07/11/2008.
Bevacizumab Side Effects Report #6018662-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 10, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion, pulmonary embolism
. Bevacizumab dosage: 550 MG, UNK. During the same period patient was treated with PACLITAXEL, OMEPRAZOLE. Patient recovered.Bevacizumab Side Effects Report #6025677-9
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Dec 19, 2008. Female patient, weighting 171.7 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: delirium, disease progression. Bevacizumab dosage: 779 MG, Q2W. During the same period patient was treated with PACLITAXEL, OXYCODONE, MORPHINE HYDROCHLORIDE, LOXOPROFEN, ACETAMINOPHEN, ALPRAZOLAM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6133949-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2009. Female patient, weighting 158.7 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, skin ulcer. Bevacizumab dosage: 1080 MG, Q3W. During the same period patient was treated with TAXOL, DICLOFENAC, TROFODERMIN, AMINOFILINA, BELACODID GOTAS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5117618-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 28, 2006. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with breast cancer female and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, disease progression, failure to thrive, fatigue. Bevacizumab dosage: 15 MG/KG Q3WKS IV. Patient was hospitalized and became disabled. Patient recovered.